ADA Oral Cancer Guidelines 2026 - American Dental Association Guideline Summary - Guideline Central
Summary of Recommendations
Document Overview

Early Detection of Oral Squamous Cell Carcinoma and Potentially Malignant Disorders

American Dental Association


Publication Date: Mar 3, 2026

Page Last Updated: May 6, 2026



Document Overview

Document Title
Early Detection of Oral Squamous Cell Carcinoma and Potentially Malignant Disorders
Authoring Society

American Dental Association

Document Publication Date
Mar 3, 2026
Page Last Reviewed/Updated
May 6, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
jada.ada.org/article/S0002-8177(26)00037-1/fulltext
Source Citation
Urquhart O, Bhosale AS, Martins-Pfeifer C, Verdugo-Paiva F, Carrasco-Labra A, Pimentel J, Sadek N, Agrawal N, Chaturvedi AK, Gurenlian J, Grayzel E, Kerr AR, Magalhaes M, Murdoch-Kinch CA, Pearson AT, Melville JC, Patel ASH, Villa A, Glick M, Lingen MW. Living evidence-informed guideline on the early detection of oral squamous cell carcinoma and potentially malignant disorders: Cytology adjuncts to determine the need for biopsy, Version 2026 1.0. J Am Dent Assoc. 2026 Mar;157(3):224-234. doi: 10.1016/j.adaj.2025.12.017. PMID: 41781073.

Martins-Pfeifer, Carolina et al. “Living evidence-informed guideline on the early detection of oral squamous cell carcinoma and potentially malignant disorders: Vital staining adjuncts to determine the need for biopsy, Version 2026 1.0.” Journal of the American Dental Association (1939), S0002-8177(26)00067-X. 6 Apr. 2026, doi:10.1016/j.adaj.2026.01.014

Document Scope, Criteria, and Use Cases

Document Objectives

These updated recommendations explore the use of four different adjuncts in early oral cancer detection. The first of a multi-part series exploring cancer detection methods assesses cytology adjuncts. Part two through four of the series will examine vital staining, light-based adjuncts, and salivary tests, respectively, to be published throughout 2026.

Early detection of oral potentially malignant disorders (OPMD) and oral squamous cell carcinoma (OSCC) can improve patient prognosis. Biopsy remains the reference standard for diagnosing OPMDs and OSCC, but advances in diagnostic technologies and living guideline methodologies have created a need for updated guidance on early cancer detection. Developed in collaboration with the Center for Integrative Global Oral Health at the University of Pennsylvania School of Dental Medicine (Penn Dental Medicine), this first of a multi-part series exploring cancer detection methods provides recommendations on when cytology adjuncts may be appropriate.

Keywords
oral cancer
Inclusion Criteria
Male, Female, Adult, Infant
Health Care Settings
Ambulatory, Outpatient
Intended Users
Dentist, Nurse, Nurse Practitioner, Physician, Physician Assistant
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.